Search In this Thesis
   Search In this Thesis  
العنوان
Protective effect of platelet-rich plasma on cisplatin induced nephrotoxicity in adult male albino rats:
المؤلف
El-Mallah, Mona Mohammed Rabah Mosa.
هيئة الاعداد
باحث / منى محمد رباح موسى الملاح
مناقش / أماني محمود العجواني
مناقش / أمل محمد امين حلاوه
مشرف / مها وجدي أبو نازل
الموضوع
Human Anatomy. Embryology.
تاريخ النشر
2022.
عدد الصفحات
97 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
تشريح
تاريخ الإجازة
29/6/2022
مكان الإجازة
جامعة الاسكندريه - كلية الطب - Human Anatomy and Embryology
الفهرس
Only 14 pages are availabe for public view

from 117

from 117

Abstract

Drug induced nephrotoxicity is defined as the presence of any kidney injury caused by medications. These injuries include sclerosis of the renal glomeruli, widening of the Bowman’s capsule, interstial fibrosis, and tubular cell necrosis. Acute kidney injury(AKI)occurs in about 25%-40% of cases treated with cisplatin, but chronic renal injury of high grades 3 or 4 is estimated to be up to 8.5%.
The aim of the present work was to study the possible protective effect of PRP on renal structure in cisplatin- induced nephrotoxicity in adult male albino rats. PRP was used as a blood product rich of growth factors in a trial to enhance renal tissue and functions.
The present study was carried out on thirty-five albino rats. Thirty adult male rats were used as the experimental group. Five age-matched healthy male albino rats were used to obtain the PRP.
The thirty adult male albino rats were randomly assigned to three groups:
 group I: (Control group) includes ten adult male albino rats received sterile sodium chloride solution 0.9% (1mL, single dose) by intraperitoneal injection on the first day as a placebo.
 group II: (cisplatin treated group) includes ten rats received cisplatin (7.5 mg/kg, single dose) by intraperitoneal injection on the first day and euthanized under anesthesia after 14 days from cisplatin injection.
 group III: (cisplatin+PRP treated group) includes ten adult male albino rats received cisplatin (7. 5 mg/kg, single dose) by intraperitoneal injection on the first day of experiment and received platelet –rich plasma (1 ml, single dose) by intraperitoneal injection after injection of cisplatin by 24 hours and euthanized under anesthesia after 14 days from cisplatin injection.